UpToDate
Official reprint from UpToDate®
www.uptodate.com ©2017 UpToDate, Inc. and/or its affiliates. All Rights Reserved.

Medline ® Abstract for Reference 82

of 'Overview of surgery in the treatment of exocrine pancreatic cancer and prognosis'

82
TI
Smoking and body mass index and survival in pancreatic cancer patients.
AU
Pelucchi C, Galeone C, Polesel J, Manzari M, Zucchetto A, Talamini R, Franceschi S, Negri E, La Vecchia C
SO
Pancreas. 2014;43(1):47.
 
OBJECTIVE: The objective of this study was to provide further information on the role of personal characteristics and lifestyle factors, including obesity, diabetes, and tobacco smoking, on survival from pancreatic cancer.
METHODS: We obtained follow-up data of pancreatic cancer patients enrolled in 2 Italian case-control studies. Information on characteristics and habits up to the time of diagnosis was collected by trained interviewers. Vital status was ascertained through population registers and record linkage with health system databases. Hazard ratios (HRs) of all-cause mortality and 95% confidence intervals (CIs) were estimated using Cox proportional hazards models.
RESULTS: Follow-up information was retrieved for 648 cancer patients. Compared with subjects with body mass index of less than 25 kg/m, the HRs were 1.14 (95% CI, 0.94-1.39) for overweight (ie, 25-29.9 kg/m) and 1.32 (95% CI, 0.98-1.79) for obese (ie,≥30 kg/m) patients (trend P = 0.046). The HRs were 1.37 (95% CI, 1.14-1.65) for ever, 1.30 (95% CI, 1.03-1.65) for ex-smokers, and 1.42 (95% CI, 1.16-1.73) for current versus never smokers. Increasing amount and duration of smoking were associated with reduced survival after pancreatic cancer. No association emerged with diabetes, alcohol consumption, and diet.
CONCLUSIONS: Smoking and overweight before diagnosis may play a role in the prognosis of pancreatic cancer, besides its etiology.
AD
From the *Dipartimento di Epidemiologia, IRCCS-Istituto di Ricerche Farmacologiche Mario Negri;†Dipartimento di Scienze Cliniche e di Comunità, Universitàdegli Studi di Milano, Milan;‡S.O.C. di Epidemiologia e Biostatistica, IRCCS-Centro di Riferimento Oncologico, Aviano (PN);§Dipartimento di Traumatologia, Ortopedia e Medicina del Lavoro, Universitàdegli Studi di Torino, Turin, Italy; and∥International Agency for Research on Cancer, Lyon, France.
PMID